Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
BNOEF BIONOMICS LTD
0.035
-0.007-16.67%
YOY
Do not show
Hide blank lines
(FY)2022/06/30(FY)2021/06/30(FY)2020/06/30(FY)2019/06/30
Total revenue
181.36K -99.16% 32.06K 1.89% 3.82M
Operating revenue
-- 181.36K -- -- -99.16% 32.06K 1.89% 3.82M
Cost of revenue
Gross profit
-99.16% 32.06K 1.89% 3.82M
Operating expense
51.91% 14.86M 11.80% 9.78M -58.11% 8.75M -36.15% 20.89M
Selling and administrative expenses
84.86% 7.84M 12.80% 4.24M -59.80% 3.76M 38.33% 9.35M
-General and administrative expense
84.86% 7.84M 12.80% 4.24M -59.80% 3.76M 38.33% 9.35M
Research and development costs
154.21% 11.01M 8.12% 4.33M -55.39% 4M -64.44% 8.98M
Depreciation amortization depletion
-- -- -- -- -- -- -- 1.71M
-Depreciation and amortization
-- -- -- -- -- -- -- 1.71M
Other operating expenses
-428.48% -3.98M 22.89% 1.21M 15.82% 987.01K 19.57% 852.2K
Operating profit
-50.05% -14.68M -12.21% -9.78M 48.91% -8.72M 41.08% -17.07M
Net non-operating interest income expense
97.82% -23.59K 12.06% -1.08M 40.98% -1.23M -40.38% -2.08M
Non-operating interest income
56.98% 6.79K -89.22% 4.32K -85.81% 40.11K -50.84% 282.65K
Non-operating interest expense
-98.30% 18.49K -14.49% 1.08M -46.34% 1.27M 14.89% 2.36M
Total other finance cost
-- 11.9K -- -- -- -- -- --
Other net income (expense)
-109.45% -395.78K -27.86% 4.19M -22.93% 5.81M 79.24% 7.53M
Gain on sale of security
-69.85% 245.01K -- 812.52K -- -- -- --
Special income (charges)
-3,988.43% -645.38K -113.21% -15.79K -- 119.51K -- --
-Less:Restructuring and merger&acquisition
-- 644.13K -- -- -- -- -- --
-Gain on sale of property,plant,equipment
92.04% -1.26K -113.21% -15.79K -- 119.51K -- --
Other non- operating income (expenses)
-99.86% 4.59K -40.35% 3.39M -24.52% 5.69M 78.38% 7.53M
Income before tax
-126.22% -15.1M -61.20% -6.68M 58.20% -4.14M 62.26% -9.91M
Income tax
6.30% -131.95K 1.29% -140.82K 39.74% -142.65K 79.61% -236.74K
Net income
-129.07% -14.97M -33.60% -6.53M 49.42% -4.89M 61.46% -9.67M
Net income continuous Operations
-129.07% -14.97M -63.43% -6.53M 58.65% -4M 61.46% -9.67M
Net income discontinuous operations
-- 0 -- -- -- -892.78K -- --
Minority interest income
Net income attributable to the parent company
-129.07% -14.97M -33.60% -6.53M 49.42% -4.89M 61.46% -9.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-129.07% -14.97M -33.60% -6.53M 49.42% -4.89M 61.46% -9.67M
Basic earnings per share
-63.49% -0.0138 -7.35% -0.0084 51.34% -0.0078 63.00% -0.0161
Diluted earnings per share
-63.49% -0.0138 -7.35% -0.0084 51.34% -0.0078 63.00% -0.0161
Dividend per share
Currency Unit
USDUSDUSDAUD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
Unqualified Opinion------

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Bionomics Ltd. is a clinical stage biopharmaceutical company. It engages in the development of novel drug candidates focused on the treatment of serious central nervous system disorders. The company was founded in 1996 and is headquartered in Eastwood, Australia.
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist